Mehrad Hamedani
Overview
Explore the profile of Mehrad Hamedani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moi L, Hamedani M, Ribi C
Clin Endocrinol (Oxf)
. 2021 Dec;
97(3):363-370.
PMID: 34908176
Background: Up to 20% of patients with moderate to severe Graves' orbitopathy (GO) do not respond to high-dose glucocorticoids (GC). A few studies, including a randomized trial, have demonstrated the...
2.
Martel A, Baillif S, Thomas P, Almairac F, Galatoire O, Hamedani M, et al.
Br J Ophthalmol
. 2021 May;
106(11):1603-1609.
PMID: 33980507
Aim: Phantom eye syndrome is a poorly understood and underestimated complication of eye removal (ER). Seeing with the amputated eye, referred to as phantom vision (PV), is undoubtedly the most...
3.
Moulin A, Pica A, Munier F, Schalenbourg A, Nobile A, Asana A, et al.
Klin Monbl Augenheilkd
. 2021 Apr;
238(4):361-364.
PMID: 33930910
No abstract available.
4.
Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Lassalle S, et al.
Surv Ophthalmol
. 2021 Feb;
66(5):856-876.
PMID: 33524457
Orbital exenteration is a radical and disfiguring surgery mainly performed in specialized tertiary care centers. Orbital exenteration has long been considered the treatment of choice for managing periocular tumors invading...
5.
Martel A, Baillif S, Thomas P, Almairac F, Galatoire O, Hamedani M, et al.
Acta Ophthalmol
. 2020 Oct;
99(5):e753-e760.
PMID: 33124153
Purpose: Phantom eye syndrome (PES) is an underestimated complication of eye amputation (EA) characterized by phantom eye pain (PEP), phantom visions and/or phantom sensations. The aim of this study was...
6.
Martel A, Oberic A, Moulin A, Zografos L, Hamedani M
Eye (Lond)
. 2018 Dec;
33(5):767-771.
PMID: 30560912
Purpose: To report the clinical and histopathologic features of two cases of eyelids metastases from uveal melanoma diagnosed in a metachronous and synchronous fashion. Methods: Monocentric retrospective case series of...
7.
Dor M, Eperon S, Lalive P, Guex-Crosier Y, Hamedani M, Salvisberg C, et al.
Exp Eye Res
. 2018 Oct;
179:64-74.
PMID: 30321513
Considering absence of invasiveness and side effects, tears emerge as a particularly attractive fluid for biomarker discovery and therefore for daily clinical use. However, to date this fluid remains poorly...
8.
Kishazi E, Dor M, Eperon S, Oberic A, Turck N, Hamedani M
Sci Rep
. 2018 Jul;
8(1):10792.
PMID: 30018377
The aim was to investigate the levels of cytokines and soluble IL-6R in the tears of patients with thyroid-associated orbitopathy (TAO) disease. Schirmer's test was adopted to collect tears from...
9.
Turck N, Eperon S, De Los Angeles Gracia M, Oberic A, Hamedani M
Dis Markers
. 2018 May;
2018:7010196.
PMID: 29736194
Background: Thyroid-associated orbitopathy (TAO) is the most common autoimmune disease of the orbit. It occurs more often in patients presenting with hyperthyroidism, characteristic of Graves' disease, but may be associated...
10.
Sherif M, Oberic A, Tiple S, Hamedani M
Klin Monbl Augenheilkd
. 2018 Apr;
235(4):448-449.
PMID: 29669373
No abstract available.